Literature DB >> 3777319

Injuries in elite orienteers.

C Johansson.   

Abstract

A prospective study of injuries in 89 elite orienteers showed a total incidence of three injuries per 1,000 training hours, with no difference between the sexes. Mean absence from training per year due to injury was 20 days for men and 19 days for women. Most injuries (80.3%) occurred during training, while the remaining injuries occurred during competition. The lower extremities were affected in 93.6% of the male injuries and in all of the female injuries. The majority of injuries (60.6%) were moderate, while 19.7% were minor and 19.7% were major injuries. Overuse injuries accounted for 57%; 43% of the injuries were due to trauma. Overuse injuries predominated in the preseason period, while the incidence was equal between overuse and traumatic injuries over the rest of the year. Of a total number of 38 overuse injuries, 60.5% occurred during running on tracks or roads. Thirteen injuries (19.7%) were major; the majority (84.6%) of these injuries were due to overuse, affecting the knee in eight cases (61.5%). Of the major injuries, 76.5% occurred during the period December to May. Of a total number of 28 traumatic injuries, 78.6% occurred while running on uneven ground, mainly in forests. Among the traumatic injuries, ankle sprains accounted for 57.1%, equally distributed between the sexes. The majority of these sprains (81.2%) were moderate. This paper will discuss injury mechanisms and possibilities of prevention.

Entities:  

Mesh:

Year:  1986        PMID: 3777319     DOI: 10.1177/036354658601400515

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  20 in total

Review 1.  Neuromotor control of the lower limb in Achilles tendinopathy: implications for foot orthotic therapy.

Authors:  Narelle Wyndow; Sallie M Cowan; Tim V Wrigley; Kay M Crossley
Journal:  Sports Med       Date:  2010-09-01       Impact factor: 11.136

2.  Conservative treatment for Insertional Achilles Tendinopathy: platelet-rich plasma and focused shock waves. A retrospective study.

Authors:  Davide Erroi; Matilde Sigona; Tania Suarez; Donatella Trischitta; Antonio Pavan; Maria Chiara Vulpiani; Mario Vetrano
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10

3.  Post-surgical care of a professional ballet dancer following calcaneal exostectomy and debridement with re-attachment of the left Achilles tendon.

Authors:  Bradley Kobsar; Joel Alcantara
Journal:  J Can Chiropr Assoc       Date:  2009-03

Review 4.  Equipment, drugs and problems of the competition and team physician.

Authors:  U M Kujala; O J Heinonen; M Lehto; M Järvinen; J A Bergfeld
Journal:  Sports Med       Date:  1988-10       Impact factor: 11.136

Review 5.  Effectiveness of orthotic devices in the treatment of Achilles tendinopathy: a systematic review.

Authors:  Lisa A Scott; Shannon E Munteanu; Hylton B Menz
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

6.  Orienteering competition injuries: injuries incurred in the Finnish Jukola and Venla relay competitions.

Authors:  P E Linko; H K Blomberg; H M Frilander
Journal:  Br J Sports Med       Date:  1997-09       Impact factor: 13.800

Review 7.  Achilles tendon injuries in athletes.

Authors:  M Kvist
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

8.  A DELPHI STUDY OF RISK FACTORS FOR ACHILLES TENDINOPATHY- OPINIONS OF WORLD TENDON EXPERTS.

Authors:  Seth O'Neill; Paul J Watson; Simon Barry
Journal:  Int J Sports Phys Ther       Date:  2016-10

Review 9.  Quantification of training in competitive sports. Methods and applications.

Authors:  W G Hopkins
Journal:  Sports Med       Date:  1991-09       Impact factor: 11.136

10.  Efficacy of customised foot orthoses in the treatment of Achilles tendinopathy: study protocol for a randomised trial.

Authors:  Shannon E Munteanu; Karl B Landorf; Hylton B Menz; Jill L Cook; Tania Pizzari; Lisa A Scott
Journal:  J Foot Ankle Res       Date:  2009-10-24       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.